Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px
Document › Details

Onxeo S.A.. (6/20/17). "Press Release: Onxeo Successfully Raises €15 Million with US and European Investors [Not for distribution in the United States, Canada, Australia and Japan]". Paris.

Organisations Organisation Onxeo S.A. (Euronext Paris, Nasdaq Copenhagen: ONXEO)
  Group Onxeo (Group)
  Organisation 2 INSTITUTIONAL INVESTORS
Products Product Livatag®
  Product 2 AsiDNA™ (Onxeo / DNA Therapeutics)
Index term Index term Onxeo–SEVERAL: investment, 201706 capital increase €15m with 3.5m new shares at €4.25/share to US + European institutional investors
Persons Person Gréciet, Judith (BioAlliance Pharma 201306 CEO + France Biotech 201508 Board Member)
  Person 2 Carmagnol, Caroline (Alize RP 201107 CEO + Founder)
     


   
Record changed: 2017-06-28

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Investors 600x60px

More documents for Onxeo (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px




» top